Start for free
Start for free
Sixth Element Capital logo

Sixth Element Capital

Europe, Buckinghamshire, United Kingdom, Berkhamsted

Description

Sixth Element Capital is a firm specializing in early stage investment.

Investor Profile

Sixth Element Capital has made 9 investments, with 0 in the past 12 months and 44% as lead.

Stage Focus

  • Series B (44%)
  • Series A (33%)
  • Seed (11%)
  • Series Unknown (11%)

Country Focus

  • United Kingdom (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Simulation
  • Translation Service
  • Health Care
  • Wellness
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sixth Element Capital frequently co-invest with?

2
2invest
Africa, Beau Vallon, Seychelles, Mahé
Co-Investments: 1
Claris Ventures
Claris Ventures
Europe, Piemonte, Italy, Torino
Co-Investments: 3
LIFTT
LIFTT
Europe, Piemonte, Italy, Turin
Co-Investments: 1
SF
Simon Fiduciaria
Europe, Piemonte, Italy, Turin
Co-Investments: 1
3B Future Health Fund
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 3
Neva SGR
Neva SGR
Europe, Piemonte, Italy, Turin
Co-Investments: 1
Astellas Venture Management
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 3
2
2invest
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 2
Epidarex Capital
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 1
Syncona Partners LLP
Syncona Partners LLP
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by Sixth Element Capital?

NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BFeb 1, 2024
Amount Raised: $12,236,423
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BJan 19, 2023
Amount Raised: $7,435,460
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BMar 9, 2021
Amount Raised: $21,108,883
Azeria Therapeutics

Cambridge, Massachusetts, United States

Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients.

BiotechnologyTherapeutics
Series BNov 21, 2019
Amount Raised: $41,340,251
Azeria Therapeutics

Cambridge, Massachusetts, United States

Azeria Therapeutics is a developer of a cancer drug intended to aid in the treatment of breast and prostate cancer patients.

BiotechnologyTherapeutics
Series ASep 4, 2018
Amount Raised: $5,143,133
AdoRx Therapeutics

Edinburgh, Edinburgh, City of, United Kingdom

AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.

BiotechnologyHealth CareTherapeutics
Series AJun 21, 2018
Amount Raised: $10,000,000
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series UnknownNov 16, 2017
Amount Raised: $3,959,920
Macrophage Pharma

Dublin, Ohio, United States

Macrophage Pharma is a immune-oncology company

BiotechnologyOncologyPharmaceuticalTherapeutics
Series AJan 9, 2017
Amount Raised: $10,953,369
Achilles Therapeutics

London, England, United Kingdom

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

BiotechnologyHealth CareTherapeuticsWellness
SeedSep 28, 2016
Amount Raised: $17,215,632
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator